Repare Therapeutics (RPTX.US) Latest Stock News - Major News Analysis

Event Tracking

Nov15

Repare Therapeutics released FY2025 Q3 earnings on November 14 EST, actual revenue USD 11.62 M (forecast USD 5 M), actual EPS USD 0.0758 (forecast USD -0.305)

04:00

Repare Therapeutics released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 11.87 M, actual EPS USD -1.0242

04:00

Aug9

Repare Therapeutics released FY2025 Semi-Annual Earnings on August 8, 2025 (EST), with actual revenue of USD 250K and EPS of USD -1.0942

03:00

Repare Therapeutics released FY2025 Q2 earnings on August 8, 2025, EST: Actual Revenue USD 250K (Forecast USD 1.667M), Actual EPS USD -0.3901 (Forecast USD -0.56)

03:00

Jul15

Repare Therapeutics Inc. Signs Exclusive Global License Agreement with Debiopharm

20:05

May14

Repare Therapeutics released FY2025 Q1 earnings on May 13 (EST), actual revenue USD 0 (forecast USD 1.667 M), actual EPS USD -0.7099 (forecast USD -0.655)

03:00